As strong and important as they seem at times, human desires do hold a known tendency of evolving drastically over time. Upon changing, these desires can also foray into different segments. This, of course, poses a big problem when the talk becomes about how to best cater such wants and needs. Hence, to achieve the said purpose, we have had to conjure up some hugely creative mediums that fit a given template without causing negative ramifications on other frontiers. Now, our success here in particular has been mixed to say the least. The quickness with which an idea can turn outdated means we always need to be on our toes, and as you can guess, that is no easy gig when you are trying to meet an expansive spectrum of interests. Nevertheless, this issue was relieved to a phenomenal extent once technology rose to the fore. You see, we were no longer forced to dabble with a huge volume of methods. Instead, we had all our solutions packaged neatly into one creation. Such a move altered the trajectory of many disciplines for the better. While it’s not to diminish technology’s impact on other areas, the difference it made for our global healthcare system has to be up there as its most important achievement. With a transformed approach, we, as a society, are now able to access a refined brand of medical attention. Furthermore, when you look at what a company like Cool Heads Care is doing for the world, you get every reason to believe that even better things might just be headed towards our horizons.
Cool Heads Care, a medtech company based in San Diego, is out to change the lives of chemotherapy patients through a cold cap therapy device called Amma. The device is specifically designed to help patients in dealing with the symptoms of hair loss, which is a common side-effect of chemotherapy treatment. It’s not news that cooling the scalp during chemotherapy can protect it from absorbing excessive amount of prescribed drugs, thus causing less hair fall, but the economic feasibility has been a sticking issue within this context for a long time. As of now, a cold cap technology can cost upto $8,000. On the other hand, though, Cool Heads Care has made the same thing available for $2,000 per patient under a pocket-friendly rental scheme.
When asked about what inspired her to create Amma, the CEO of Cool Heads Care, Kate Dilligan said:
“I built our cold cap therapy device, Amma, because all chemotherapy patients with solid tumors deserve a choice as to whether or not they want to endure one of the most noticeable side effects of cancer treatment.”
By also offering training for how to effectively use the device, Cool Heads Care plans on making the device as universal as possible. Amma recently received an official clearance from FDA and it now eyes a release somewhere in the first quarter of 2022.